Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.45 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
| ▸ | XPO1 | O14980 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43004 | 1.00 | HCAR2 (0.45) | HCAR2KEAP1NFE2L2DGAT1ATM | |
| SCHEMBL375029 | 1.00 | HCAR2 (0.45) | HCAR2KEAP1NFE2L2DGAT1ATM | |
| SCHEMBL19008840 | 0.92 | HCAR2 (0.39) | HCAR2KEAP1NFE2L2DGAT1ATM | |
| SCHEMBL642104 | 0.89 | HCAR2 (0.54) | HCAR2KEAP1NFE2L2DGAT1TDP1 | |
| SCHEMBL642105 | 0.89 | HCAR2 (0.54) | HCAR2KEAP1NFE2L2DGAT1TDP1 | |
| SCHEMBL3878185 | 0.89 | HCAR2 (0.38) | HCAR2KEAP1NFE2L2DGAT1PRKCA | |
| SCHEMBL8451389 | 0.89 | NFE2L2 (0.65) | HCAR2KEAP1NFE2L2DGAT1LMNA | |
| SCHEMBL14999614 | 0.89 | HCAR2 (0.38) | HCAR2KEAP1NFE2L2DGAT1PRKCA | |
| SCHEMBL8449337 | 0.89 | NFE2L2 (0.65) | HCAR2KEAP1NFE2L2DGAT1LMNA | |
| SCHEMBL8449347 | 0.89 | NFE2L2 (0.65) | HCAR2KEAP1NFE2L2DGAT1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036783-A | Organosilicon modified polyaspartic acid ester polyurea and preparation method thereof | 深圳市宝安区新材料研究院 | 2026-05-15 | — | — | CN | claimed |
| US-20260078213-A1 | METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE | ARKEMA FRANCE (FR) | 2026-03-19 | — | — | US | claimed |
| EP-4587497-A1 | METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE | ARKEMA FRANCE (FR) | 2025-07-23 | — | — | EP | claimed |
| CN-115244063-B | Ligands for transition metal catalysts | 罗特格斯新泽西州立大学 | 2025-03-07 | — | — | CN | claimed |
| WO-2024056688-A1 | METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE | ARKEMA FRANCE (FR) | 2024-03-21 | — | — | WO | claimed |
| CN-114805731-B | Low-reactivity polyaspartic acid ester resin, preparation method, coating and preparation method | 深圳飞扬骏研新材料股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115181487-B | High-molecular repairing agent for concrete ground tortoise cracks | 星地元新材料股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-115181487-A | Concrete floor tortoise crack polymer repairing agent | 星地元新材料股份有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-115028832-A | Preparation method of water-based polyaspartic ester resin and water-based PAE polyurea coating | 浙江科技学院 | 2022-09-09 | — | — | CN | claimed |
| CN-114805731-A | Low-reactivity polyaspartic acid ester resin, preparation method thereof, paint and preparation method thereof | 深圳飞扬骏研新材料股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-5525656-A | HEAT SEALABLE COMPOSITION CONSISTING OF VINYL ESTER COPOLYMER IN ORGANIC SOLVENT; HALOGEN-FREE | WACKER CHEMIE GMBH (DE) | 1996-06-11 | — | — | US | claimed |
| EP-0244835-B1 | LANGMUIR-BLODGETT ULTRATHIN MEMBRANE OF POLYFUMURATE | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1992-08-26 | — | — | EP | claimed |
| EP-0192997-B1 | METHOD FOR MODIFYING POLYFUMARIC ACID DIESTER | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1992-04-29 | — | — | EP | claimed |
| EP-0233299-B1 | OPTICAL RESIN AND PROCESS FOR PREPARING THE SAME | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-03-13 | — | — | EP | claimed |
| US-4978722-A | VAPOR PHASE POLYMERIZATION USING COORDINATION CATALYSTS AND CARBOXYLIC OR PHOSPHORUS ESTERS, AMINES OR AMIDES | MITSUBISHI KASEI CORPORATION (JP) | 1990-12-18 | — | — | US | claimed |
| US-4907038-A | Langmuir Blodgett ultrathin membrane of polyfumarate | NIPPON OIL AND FATS CO., LTD. (JP) | 1990-03-06 | — | — | US | claimed |
| US-4855374-A | Optical resin from diallyl esters | NIPPON OIL AND FATS CO., LTD. (JP) | 1989-08-08 | — | — | US | claimed |
| EP-0244835-A2 | Langmuir-Blodgett ultrathin membrane of polyfumurate | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1987-11-11 | — | — | EP | claimed |
| EP-0233299-A1 | Optical resin and process for preparing the same | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1987-08-26 | — | — | EP | claimed |
| EP-0192997-A2 | Method for modifying polyfumaric acid diester | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1986-09-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078213-A1 | METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE | SRM, JMJD6, MAT1A | HCAR2 165/4885KEAP1 936/4885NFE2L2 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.